Go back

UK medicines agency to speed up innovative drug production


MHRA to amend Human Medicines and Clinical Trials legislation to unleash drug innovation

The UK drugs agency is planning to help speed up production of innovative medicines, such as cell and gene therapy, through amending the 2004 Human Medicines and Clinical Trials legislation later this year.

The goal is to cut red tape and get medicines to patients more quickly, and to benefit innovators “by providing clear regulatory expectations and enabling easier product development”, said the Medicines and Healthcare products Regulatory Agency on 25 January.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.